INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 413m ago
HOUSE PTR13m ago
SEC 13F13m ago
ROBINHOOD CHAIN13m ago
Corporate insider
CP

Carr Patricia

SVP, Chief Accounting OfficerCIK 0001784606

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 4
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
2,370 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcSVP, Chief Accounting Officer · Nov 20, 2025
36
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL
$770K
4,500 sh
Dec 5, 2025
Dec 9, 2025
traded Dec 5, 2025
+4d
SEC FORM 4

Evidence

5
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
4,500 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

22
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$27K
160 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

23
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M$633K
4,500 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

21
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$13K
69 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

27
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M$715K
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

9
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

35
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$956K
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence